News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Ritract Ltd Release: Australian Safety Syringe Gets Clearance To Market In The United States
June 8, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SYDNEY, Australia, June 8 /PRNewswire-FirstCall/ -- Ritract (ASX: RTL - News) Limited today reported US Food & Drug Administration (FDA) clearance to begin marketing its range of auto-retractable safety syringes in the USA.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Regulatory
Australia
MORE ON THIS TOPIC
Approvals
GSK Wins Asthma Approval for Anti-Inflammatory Antibody
December 17, 2025
·
2 min read
·
Tristan Manalac
Podcast
Lilly’s Triple Triumph, Prasad’s COVID Error, J&J’s Surprise Voucher, M&A Targets
December 17, 2025
·
2 min read
·
Heather McKenzie
Insights
Uptick in Dealmaking, Chinese Partnerships Drive Biotech’s Comeback
December 17, 2025
·
3 min read
·
Jennifer Smith-Parker
Vaccines
Makary Denies FDA Plans To Levy Black Box Warning on COVID-19 Vaccines
December 16, 2025
·
3 min read
·
Heather McKenzie
